FINWIRES · TerminalLIVE
FINWIRES

RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276

By

ResMed (RMD) has an average rating of overweight and mean price target of $266.02, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles

Research

Barclays Upgrades PayPal to Equalweight From Underweight

PayPal (PYPL) has an average rating of hold and mean price target of $48.11, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $57.35, Change: $+1.83, Percent Change: +3.30%

$PYPL
Research

Baird Upgrades UnitedHealth Group to Neutral From Underperform, Price Target is $453

UnitedHealth Group (UNH) has an average rating of overweight and mean price target of $444.60, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $433.07, Change: $+14.55, Percent Change: +3.48%

$UNH
Research

Stephens Downgrades Distribution Solutions Group to Equalweight From Overweight, Price Target is $35

Stephens Downgrades Distribution Solutions Group to Equalweight From Overweight, Price Target is $35

$DSGR